pharma.pet
ActiveSummary
The computed 12-month bankruptcy probability of pharma.pet is 7.4% (elevated). The 2024 annual accounts show negative equity (-€414,432) and a net result of -€156,967. Equity is shrinking by about 53% per year across the filed financial years. Its solvency ranks better than 6% of 8,969 sector peers (NACE 46, financial year 2024). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
15%
According to the 2021 annual accounts of pharma.pet and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
The network starts from this company’s shareholders. What else they own or run appears here as nodes.